International Journal of Cancer Management

Published by: Shiraz University of Medical Sciences

Trends in Ovarian Cancer Incidence in Iran

Yousef Moradi 1 , Mehdi Jafari 2 , Shahla Chaichian 3 , * , Sorour Khateri 4 , Abdolrasool Akbarian 1 , Bahram Moazzami 1 , Kamyar Mansori 5 , Yaghob Mahmodi 6 and Saeed Samie 1
Authors Information
1 Pars Advanced and Minimally Invasive Manners Research Center, Pars Hospital, Iran University of Medical Sciences Tehran, Iran
2 Departemanet of Surgery, Research Center for Improvement of Surgical Outcome and Procedures, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
3 Minimally Invasive Techniques Research Center in Women, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
4 MD, Social Determinants of Health Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran
5 Social Development and Health Promotion Research Center, Gonabad University of Medical Sciences , Gonabad, Iran
6 Master of Medical Surgical Nursing Education, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Journal of Cancer Prevention: December 2016, 9 (6); e5452
  • Published Online: December 7, 2016
  • Article Type: Research Article
  • Received: January 23, 2016
  • Accepted: December 3, 2016
  • DOI: 10.17795/ijcp-5452

To Cite: Moradi Y, Jafari M, Chaichian S, Khateri S, Akbarian A, et al. Trends in Ovarian Cancer Incidence in Iran, Int J Cancer Manag. 2016 ;9(6):e5452. doi: 10.17795/ijcp-5452.

Abstract
Copyright © 2016, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Becker AE, Hernandez YG, Frucht H, Lucas AL. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. World J Gastroenterol. 2014; 20(32): 11182-98[DOI][PubMed]
  • 2. Blake EA, Sheridan TB, Wang KL, Takiuchi T, Kodama M, Sawada K, et al. Clinical characteristics and outcomes of uterine tumors resembling ovarian sex-cord tumors (UTROSCT): a systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2014; 181: 163-70[DOI][PubMed]
  • 3. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol. 2009; 20(3): 556-63[DOI][PubMed]
  • 4. Tabei SZ, Heydari ST, Mehrabani D, Shamsina SJ, Ahmadi J, Firouzi SM. Current substance use in patients with gastric cancer in Southern Iran. J Cancer Res Ther. 2006; 2(4): 182-5[DOI][PubMed]
  • 5. Alsayyad J, Hamadeh R. Cancer incidence among the Bahraini population: a five-year (1998-2002) experience. Ann Saudi Med. 2007; 27(4): 251-8[DOI][PubMed]
  • 6. Askarian M, Goli A, Oroei M, Faramarzi H. The geographical clusters of gastrointestinal tract cancer in fars province, southern iran. Int J Prev Med. 2014; 5(7): 857-64[PubMed]
  • 7. Cabanes A, Vidal E, Aragones N, Perez-Gomez B, Pollan M, Lope V. Cancer mortality trends in Spain. Annals Oncol. 2010; 21(3): 1980-2007
  • 8. Cook O, McIntyre M, Recoche K. Exploration of the role of specialist nurses in the care of women with gynaecological cancer: a systematic review. J Clin Nurs. 2015; 24(5-6): 683-95[DOI][PubMed]
  • 9. Cripe J, Tseng J, Eskander R, Fader AN, Tanner E, Bristow R. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent ovarian carcinoma: analysis of 30-day morbidity and mortality. Ann Surg Oncol. 2015; 22(2): 655-61[DOI][PubMed]
  • 10. Diaz Mdel P, Osella AR, Aballay LR, Munoz SE, Lantieri MJ, Butinof M, et al. Cancer incidence pattern in Cordoba, Argentina. Eur J Cancer Prev. 2009; 18(4): 259-66[DOI][PubMed]
  • 11. Etemadi A, Sadjadi A, Semnani S, Nouraie SM, Khademi H, Bahadori M. Cancer registry in Iran: a brief overview. Arch Iran Med. 2008; 11(5): 577-80[PubMed]
  • 12. Ferraro S, Schiumarini D, Panteghini M. Human epididymis protein 4: factors of variation. Clin Chim Acta. 2015; 438: 171-7[DOI][PubMed]
  • 13. Hassan S, Muere A, Einstein G. Ovarian hormones and chronic pain: A comprehensive review. Pain. 2014; 155(12): 2448-60[DOI][PubMed]
  • 14. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60(5): 277-300[DOI][PubMed]
  • 15. Karlsen NS, Karlsen MA, Hogdall CK, Hogdall EV. HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic review. Cancer Epidemiol Biomarkers Prev. 2014; 23(11): 2285-95[DOI][PubMed]
  • 16. Kodama M, Grubbs BH, Blake EA, Cahoon SS, Murakami R, Kimura T, et al. Feto-maternal outcomes of pregnancy complicated by ovarian malignant germ cell tumor: a systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2014; 181: 145-56[DOI][PubMed]
  • 17. Kotsopoulos J, Prescott J, De Vivo I, Fan I, McLaughlin J, Rosen B, et al. Telomere length and mortality following a diagnosis of ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2014; 23(11): 2603-6[DOI][PubMed]
  • 18. Lankarani KB, Khosravizadegan Z, Rezaianzadeh A, Honarvar B, Moghadami M, Faramarzi H, et al. Data coverage of a cancer registry in southern Iran before and after implementation of a population-based reporting system: a 10-year trend study. BMC Health Serv Res. 2013; 13: 169[DOI][PubMed]
  • 19. Le PN, McDermott JD, Jimeno A. Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28. Pharmacol Ther. 2015; 146: 1-11[DOI][PubMed]
  • 20. Masoompour SM, Yarmohammadi H, Rezaianzadeh A, Lankarani KB. Cancer incidence in southern Iran, 1998-2002: results of population-based cancer registry. Cancer Epidemiol. 2011; 35(5): 42-7[DOI][PubMed]
  • 21. Karimi M, Mehrabani D, Yarmohammadi H, Jahromi FS. The prevalence of signs and symptoms of childhood leukemia and lymphoma in Fars Province, Southern Iran. Cancer Detect Prev. 2008; 32(2): 178-83[DOI][PubMed]
  • 22. Kolahdoozan S, Sadjadi A, Radmard AR, Khademi H. Five common cancers in Iran. Arch Iran Med. 2010; 13(2): 143-6[PubMed]
  • 23. Mirzadeh M, Mirzaei M, Mirzaei M, ShogaeiFar H. Years of Life Lost and Childhood and Adolescent Cancer Mortality in Yazd Province, Iran (2004-2009). Iran J Ped Hematol Oncol. 2015; 5(3): 125-30[PubMed]
  • 24. Orozco LJ, Tristan M, Vreugdenhil MM, Salazar A. Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women. Cochrane Database Systematic Reviews. 2014; 7: 5638[DOI]
  • 25. Resta G, Vedana L, Marino S, Scagliarini L, Bandi M, Anania G. Isolated splenic metastasis of ovaric cancer. Case report and literature review. G Chir. 2014; 35(7-8): 181-4[DOI][PubMed]
  • 26. Siesling S, van Dijck JA, Visser O, Coebergh JW, Working Group of The Netherlands Cancer R. Trends in incidence of and mortality from cancer in The Netherlands in the period 1989-1998. Eur J Cancer. 2003; 39(17): 2521-30[DOI][PubMed]
  • 27. Penault-Llorca F, Bertucci F, Adelaide J, Parc P, Coulier F, Jacquemier J, et al. Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer. 1995; 61(2): 170-6[DOI][PubMed]
  • 28. Sadeghi A, Behmard S, Shafiepoor H, Zeighmani E. Cancer of the esophagus in southern Iran. Cancer. 1977; 40(2): 841-5[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments